ScholarWorks@Gachon: Shin, Dong Yun

Detailed Information

Shin, Dong Yun (신동윤)

Pharmacy (Dept.of Pharmacy)

Research Area

Tel 032-820-4945
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

synthesis:4||daurinol:3||Anticancer:3||Antiamoebic:2||Rheumatoid arthritis:2||mechanism:2||Metronidazole:2||Beauveria bassiana:2||Total synthesis:2||regulatory T cells:2||STX0119:2||rheumatoid arthritis:2||Microglia:2||Cancer:2||Type 2 diabetes:2||NFκB:2||Quinone reductase:2||targeted protein degradation:2||catalysis:2||6shogaol:2||Gymnasterkoreayne:2||Structureactivity relationship:2||Amoebiasis:2||Entamoeba histolytica:2||Daurinol:2||Lignan:2||Chemoprevention:2||Ceramide:1||Chaga mushroom:1||Chemopreventive:1||Chiral resolution:1||Cirrhosis:1||Cisplatin:1||Click chemistry:1||Coenzyme Q10:1||Colorectal cancer:1||Combined therapy:1||Corniculatolide B:1||Cysteinyl peptide enrichment:1||DHPV:1||DNA polymerase:1||DNA tetrahedron:1||Diabetes:1||Diabetic nephropathy:1||Divergent synthesis:1||Diyne:1||Drug design:1||Drug resistance:1||ERK1/2:1||Entamoeba histolytic:1||Enzyme delivery:1||Equol:1||Ergosterol peroxide:1||FAK:1||FDA:1||FOXP3 hypomethylation:1||Firmiana simplex:1||FriedelCrafts reaction:1||GPR40 agonist:1||GPR40 agonists:1||Glucagon receptor antagonist:1||Glycol chitosan coating:1||Glycoslyation:1||Gold nanocage:1||Gold nanoparticles:1||Hepatic stellate cell:1||Heterocycle:1||Hyaluronic acid:1||Hydantoin:1||IBD:1||IL17:1||IL17producing T cells:1||Imidazolidine2,4dione:1||Immune modualtion:1||Imperata cylindrica:1||Inflammatory bowel diseases:1||Inflammatory cytokines:1||Inhibitor:1||Intramolecular DielsAlder:1||Isomeric corniculatolides:1||IκBα:1||Joint inflammation:1||Justicidin:1||KEAP1:1||KRAS inhibitors:1||KRAS mutant:1||LPA(1):1||Lewis acid:1||Liposomes:1||Liver:1||Liver fibrosis:1||Lysophosphatidic acid:1||Lysophosphatidic acid receptor 1:1||MITassay:1||MRSA:1||MYC:1||Mass spectrometry:1||Medicinal:1||Medicinal chemistry:1||Membrane fusion:1||Metabolites:1||MicrobiotaGutBrain axis:1||Modified nucleotide:1||NFAT reporter assay:1||NRF2:1||NSCLC:1||Natural:1||Nearinfrared photosensitizer:1||Necroptosis:1||Neurodegeneration:1||Neurodegenerative disease:1||Neuroinflammation:1||Neuroprotection:1||NewmanKwart:1||Oxidative stress:1||P75 neurotrophin receptor:1||PDK1:1||PROTAC:1||PTP1B inhibitor:1||Parkinson's disease:1||Peptide fractionation:1||Phenylpyrimidine:1||Phototherapy:1||Plasmodium falciparum:1||Privileged structure:1||Protac:1||Protein degradation:1||Proteolysistargeting chimera (PROTAC):1||Proteus mirabilis:1||Protozoan:1||Quantification:1||RAS:1||RIPK3 protein:1||ROR alpha:1||Reactive oxidative stress:1||Regioselectivity:1||Rejuvenation:1||Resvebassianol A:1||Resveratrol:1||Reversible terminator:1||STAT3:1||STAT3 inhibitor:1||Senolytics:1||Septic brain:1||Sequencingbysynthesis:1||Signal transducer and activator of transcription 3 inhibitor:1||Soonsil Hyun and Dongyun Shin:1||Stereoisomeric:1||Streptavidinmirror DNA tetrahedron hybrid:1||Suzuki:1||Synthesis:1||T helper 17:1||TACE:1||TMPA:1||TNFalpha:1||Targeted protein degradation (TPD):1||Thiohydantoin:1||Thioredoxin reductase:1||Treg:1||Triazole:1||Triphosphate:1||Type 2 diabetes mellitus:1||Ubiquitinproteasome system:1||Ulcerative colitisInflammation:1||WD40repeat domain protein 5 (WDR5):1||WDR5MYC interaction inhibitors:1||Xenograft:1||advantages:1||alkylation:1||amino acids:1||angiogenesis:1||antitumor:1||apoptosis:1||approve:1||arylnaphthalene:1||asymmetric:1||betacatenin:1||bicyclic compounds:1||biotransformation:1||biphenyl:1||breast cancer:1||cancer therapy:1||carbocycles:1||carbonylation:1||cell cycle:1||cell differentiation:1||cell rejuvenation:1||chiral:1||coenzyme Q10:1||cyclization:1||cytosporones:1||degrader:1||diastereoselectivity:1||disease:1||drug:1||edible medicinal herb:1||giardiasis:1||ginger:1||glucagon receptor antagonist:1||glucosestimulated insulin secretion (GSIS):1||glycosides:1||immunity:1||immunomodulatory:1||indole5propanoic acid:1||inflammatory bowel disease:1||inhibitor:1||interleukin receptorassociated kinase (IRAK) proteins:1||intramolecular:1||lactone:1||leishmaniasis:1||lignan:1||limitations:1||linker flexibility:1||lung cancer:1||malaria:1||mansonones:1||medicinal chemistry:1||melanocortin:1||metastasis:1||microarray analysis:1||modulator:1||neuroinflammation:1||neuropilin 1:1||neuroprotection:1||octaketides:1||oncogene:1||orthoquinones:1||osteoclastogenesis:1||ovarian cancer:1||oxidation:1||pSTAT3:1||palladium:1||parasitic:1||peptide:1||permeability:1||phytoestrogen:1||proteolysistargeting chimeras:1||protozoan diseases:1||psoriasis:1||quinazoline:1||quinazolines:1||receptor:1||resveratrol:1||secondary leukemia:1||selectivity:1||sphingolipid:1||stability:1||sulfonamide:1||thiaphenalene:1||topoisomerase II alpha inhibitor:1||transition metal:1||transitionmetal:1||transitionmetalfree:1||trichomoniasis:1||2Iminothiazoline:1||trypanosomiasis:1||2quinolone:1||AM095:1||AOM/DSS:1||ATP binding pocket:1||Activity:1||Aging:1||Akt:1||Antiinflammatory activity:1||Antiinflammatory effect:1||Antidiabetics:1||Apoptosis:1||Aryl carbamate:1||Arylnaphthalene:1||Arylnaphthalene lactone:1||Arylnaphthalene lactones:1||Aryltetrahydronaphthalene:1||Asymmetric:1||Asymmetric dihydroxylation:1||Autophagy:1||Balanophonin:1||Benzoin condensation:1||Bioisosteric:1||Bioluminescence intensity (BLI):1||Biopolymer coating:1||CU051189:1||Cancer therapy:1||

RSS_1.0 RSS_2.0 ATOM_1.0

1342, Seongnam-daero, Sujeong-gu, Seongnam-si, Gyeonggi-do, Republic of Korea(13120)031-750-5114

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE